Clinical trials for Dravet syndrome
12 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07251673Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene MutationAssistance Publique - Hôpitaux de Paris · PI: Stéphane Auvin, MD, PhD
- RECRUITINGPhase 3NCT06872125A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeStoke Therapeutics, Inc
- RECRUITINGPhase 4NCT06598449Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeUniversity of Colorado, Denver · PI: Kelly Knupp, MD
- RECRUITINGPhase 3NCT06660394A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)Longboard Pharmaceuticals
- ACTIVE NOT RECRUITINGPhase 3NCT06118255A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromeUCB BIOSCIENCES, Inc. · PI: UCB Cares
- RECRUITINGPHASE1, PHASE2NCT05419492A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet SyndromeEncoded Therapeutics · PI: Salvador Rico, M.D., Ph.D
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06283212A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet SyndromeEncoded Therapeutics · PI: Salvador Rico, M.D., Ph. D
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06112275A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)Encoded Therapeutics · PI: Salvador Rico, M.D., Ph.D
- ENROLLING BY INVITATIONN/ANCT06371794EXploring novEl Molecular Determinants of DRAvet Syndrome Phenotype HeterogeneityFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT05651204GABA Biomarkers in Dravet SyndromeCook Children's Health Care System · PI: Christos Papadelis, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT04740476An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeStoke Therapeutics, Inc · PI: Ann Dandurand, MD
- RECRUITINGPhase 3NCT04462770A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeEpygenix · PI: Amit Ray, MD